PacBio designs long-read DNA sequencing systems that help researchers read complete genomes, transcriptomes, and epigenomes. Its Revio and Vega platforms use proprietary HiFi sequencing chemistry, combining the completeness of long reads with the accuracy of short reads, supported by library prep kits, reagents, and the SMRT Link software suite. Specialized tools such as Kinnex for full-length RNA sequencing and PureTarget for targeted enrichment extend the platform into human genomics, oncology, microbial, agricultural, and biopharma research. What sets PacBio apart is its focus on accuracy and completeness over raw throughput, giving scientists confidence in genomic regions that short-read technologies often miss. The goal is to enable the promise of genomics to advance human health.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Help us improve and share your feedback! Did you find this helpful?